Early research (Phase 1)Study completedNCT02161224
What this trial is testing
Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function
Who this might be right for
PK of FG-4592Hepatic InsufficiencyHealthy Subjects
Astellas Pharma Europe B.V. 16